featured
Effects of Semaglutide Use on Obesity in Patients Undergoing Dialysis for Kidney Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Semaglutide in patients with kidney failure and obesity undergoing dialysis and wishing to be transplanted: A prospective, observational, open-label study
Diabetes Obes Metab 2024 Oct 07;[EPub Ahead of Print], L Vanek, A Kurnikowski, S Krenn, S Mussnig, M HeckingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.